Search

Your search keyword '"Emma Tomlinson"' showing total 100 results

Search Constraints

Start Over You searched for: Author "Emma Tomlinson" Remove constraint Author: "Emma Tomlinson" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
100 results on '"Emma Tomlinson"'

Search Results

1. Evaluating patient experience to improve care in a specialist antenatal clinic for pregnancy after loss

2. Community established best practice recommendations for tephra studies—from collection through analysis

3. Determining the Key Predictive Factors for Non-Union in Fifth Metatarsal Fractures: A Machine Learning-Based Study

5. Supplementary Figure 5 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

6. Supplementary Figure 3 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

7. Supplementary Figure 4 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

8. Supplementary Figure 2 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

9. Supplementary Figure 6 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

10. Supplementary Figure 1 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

11. Supplementary Materials and Methods from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

12. Data from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

13. Laki 1783-84 AD tephra linked mercury enrichment in peat at Brackloon Wood, Mayo, Ireland

14. Supplementary Figure 3 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

16. Supplementary Figure 4 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

17. Supplementary Figure 6 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

18. Supplementary Figure 5 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

19. Data from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

20. Supplementary Figure 2 from Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

21. Deep ultra-hot melting in cratonic mantle roots

22. Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations

23. Chloroquine treatment induces secretion of autophagy-related proteins and inclusion of Atg8-family proteins in distinct extracellular vesicle populations

32. Pomegranate protects liver against cecal ligation and puncture-induced oxidative stress and inflammation in rats through TLR 4 /NF‐κB pathway inhibition

33. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor

34. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles

35. Identification of a Potent Antiandrogen that Targets the BF3 Site of the Androgen Receptor and Inhibits Enzalutamide-Resistant Prostate Cancer

36. Characterization of a New Class of Androgen Receptor Antagonists with Potential Therapeutic Application in Advanced Prostate Cancer

37. Understanding urinary conditioning film components on ureteral stents: profiling protein components and evaluating their role in bacterial colonization

38. Allelic loss of the loci containing the androgen synthesis gene, StAR , is prognostic for relapse in intermediate-risk prostate cancer

39. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3′-diindolylmethane (Ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells

40. Methods for the purification of ubiquitinated Proteins

41. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor

42. DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis

43. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor

44. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease

45. Targeting the binding function 3 (BF3) site of the androgen receptor through virtual screening. 2. development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole derivatives

46. Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening

47. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells

48. Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer

49. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer

50. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles

Catalog

Books, media, physical & digital resources